Clinical Trials Logo

Clinical Trial Summary

There will be two phases of this study. The phases of this study may occur simultaneously. In Phase I, eligible subjects will be asked to acutely wear the Alio Medical RMS SmartPatch during regularly scheduled dialysis sessions. Subjects will have a pre- and post-dialysis blood draw(s), vitals collected, and monitoring throughout the dialysis sessions. The SmartPatch will be removed from the location(s) where it is placed following the post-dialysis blood draw. In Phase II, subjects will be asked to wear a SmartPatch for up to 90 days. Subjects will be trained on the use of the Alio Medical RMS and be provided a system for them to utilize at home. Patches will be changed at a minimum of once every 7 days.


Clinical Trial Description

There will be two phases of this study. The phases of this study may occur simultaneously. For Phase I subjects' consent will be completed via RedCap in person upon their first study related dialysis visit. In Phase I, eligible subjects will be asked to acutely wear the Alio Medical RMS SmartPatch during regularly scheduled dialysis sessions.The SmartPatch automatically records data and uploads it to the Alio Cloud. Subjects will have a pre- and post-dialysis blood draw(s), vitals collected, and monitoring throughout the dialysis sessions. The SmartPatch will be removed from the location(s) where it is placed following the post-dialysis blood draw. For Phase II consent will be completed via RedCap either in clinic during a visit to pick up supplies or via email and digital communication if the subject is unable to drive to the clinic location. In Phase II, subjects will be asked to wear a SmartPatch for up to 90 days. The exact wear time will be documented on the case report form (CRF). Any request for specific wear times and frequency of SmartPatch changes will be documented prior to study start on the consent form or CRF. This will be done to enable continuous non-invasive measurements of the patient metrics (e.g., hemoglobin (Hb), hematocrit (Hct),heart rate (HR), and other relevant dialysis labs or vitals). Subjects will be trained on the use of the Alio Medical RMS and be provided a system for them to utilize at home. Patches will be changed at a minimum of once every 7 days. In addition to At-Home device use, subjects will also be participating in acute data collection during one (or more) of their in-clinic or at home dialysis sessions. Approximately every two to four weeks over the course of Phase 2, subjects will have a pre- and post-dialysis blood draw(s), vitals collected, and SmartPatch monitoring. Further, any procedures, hospitalizations or additional relevant labs/imaging will also be collected for the purposes of comparing the Alio Medical RMS to standard of care assessments. At the end of the study, subjects maybe asked to complete a short survey on their experience with the Alio Medical RMS. Select study staff will have access to Alio Medical RMS study data for the purposes of comparing this information to the clinical standard(s) collected. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05039541
Study type Observational
Source Alio Medical
Contact Emilee Scates
Phone 7203130218
Email [email protected]
Status Not yet recruiting
Phase
Start date September 1, 2021
Completion date September 1, 2022

See also
  Status Clinical Trial Phase
Completed NCT05018962 - Recurrent Stenoses in Arteriovenous Fistula (AVF) for Dialysis Access: CuttIng ballooN angioplaSTy Combined wITh Paclitaxel drUg coaTed Balloon Angioplasty, an observatIONal Clinical Study Phase 2
Active, not recruiting NCT04629118 - Intervention With Selution SLRâ„¢ Agent Balloon for Endovascular Latent Limus Therapy for Failing AV Fistulas (ISABELLA) Trial
Completed NCT04698512 - MAgicTouchâ„¢ Intervention Leap for Dialysis Access (MATILDA) Trial
Recruiting NCT02056704 - Trial Comparing Angiography and Angiography With IVUS for Treatment of Hemodialysis Access Failures Phase 4
Enrolling by invitation NCT04381754 - Use of Implanting the Biotronik Passeo-18 Lux Drug Coated Balloon to Treat Failing Haemodialysis Arteriovenous Fistulas and Grafts.
Enrolling by invitation NCT04054440 - Outpatient Office Based Endovascular Procedures
Completed NCT04430478 - Volume Flow-guided Angioplasty of Dysfunctional Dialysis Access N/A
Recruiting NCT04694287 - Volume Flow Assessment to Optimize Angioplasty of Dysfunctional Dialysis Access
Not yet recruiting NCT04914949 - The Match Study in ESRD Patients
Recruiting NCT04692636 - BP Variability on the Outcomes of Hemodialysis Vascular Access
Recruiting NCT04796558 - Validation of Arterio Venous Access Stage (AVAS) Classification
Recruiting NCT04988789 - Evaluation of Paclitaxel Coated Balloon in the Treatment of Dialysis Access Dysfunction